Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of sequential epirubicin and docetaxel versus docetaxel in early operable breast cancer
2007-003126-15Phase 3Completed
- Sponsor
- Danish Breast Cancer Cooperative Group
- Start
- Mar 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of docetaxel in breast cancer (2 arms), sponsored by Danish Breast Cancer Cooperative Group. Primary endpoint: Invasive disease-free survival. Started Mar 2008; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-003126-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003126-15.